Search research articles
Contact Us
Filters
Showing results (11-20 of 149) with videos related to
Page
of 15
Sort By:
BMC Medical Genomics
|
June 8, 2010
SEURAT: visual analytics for the integrated analysis of microarray data
Alexander Gribov, Martin Sill, Sonja Lück, et al.
Proteomics. Clinical Applications
|
December 11, 2013
Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays
Christoph Schröder, Harish Srinivasan, Martin Sill, et al.
Genes, Chromosomes & Cancer
|
October 23, 2010
Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML
Frank G Rücker, Lars Bullinger, Alexander Gribov, et al.
Proteomics
|
March 11, 2014
Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses
Harish Srinivasan, Yves Allory, Martin Sill, et al.
Microarrays (Basel, Switzerland)
|
September 8, 2016
Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays
Martin Sill, Christoph Schröder, Ying Shen, et al.
Acta Neuropathologica Communications
|
June 24, 2025
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing
Dean Thompson, Jemma Castle, Martin Sill, et al.
Nature Communications
|
February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Salvatore Benfatto, Martin Sill, David T W Jones, et al.
Acta Neuropathologica
|
November 25, 2025
IDH mutations are rare events in SHH medulloblastoma
Alicia Fürst, Viktoria Ruf, Christian Fiedler, et al.
International Journal of Cancer
|
October 24, 2018
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas
Steffen Dietz, Aviezer Lifshitz, Daniel Kazdal, et al.
Oncotarget
|
December 19, 2018
Limitations of current <i>in vitro</i> models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
Hazel Anne Rogers, Rebecca Chapman, Holly Kings, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 149) with videos related to
Sort By:
Page
of 15
BMC Medical Genomics
|
June 8, 2010
SEURAT: visual analytics for the integrated analysis of microarray data
Alexander Gribov, Martin Sill, Sonja Lück, et al.
Proteomics. Clinical Applications
|
December 11, 2013
Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays
Christoph Schröder, Harish Srinivasan, Martin Sill, et al.
Genes, Chromosomes & Cancer
|
October 23, 2010
Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML
Frank G Rücker, Lars Bullinger, Alexander Gribov, et al.
Proteomics
|
March 11, 2014
Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses
Harish Srinivasan, Yves Allory, Martin Sill, et al.
Microarrays (Basel, Switzerland)
|
September 8, 2016
Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays
Martin Sill, Christoph Schröder, Ying Shen, et al.
Acta Neuropathologica Communications
|
June 24, 2025
Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing
Dean Thompson, Jemma Castle, Martin Sill, et al.
Nature Communications
|
February 20, 2025
Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics
Salvatore Benfatto, Martin Sill, David T W Jones, et al.
Acta Neuropathologica
|
November 25, 2025
IDH mutations are rare events in SHH medulloblastoma
Alicia Fürst, Viktoria Ruf, Christian Fiedler, et al.
International Journal of Cancer
|
October 24, 2018
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas
Steffen Dietz, Aviezer Lifshitz, Daniel Kazdal, et al.
Oncotarget
|
December 19, 2018
Limitations of current <i>in vitro</i> models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
Hazel Anne Rogers, Rebecca Chapman, Holly Kings, et al.
Page
of 15